Entity

Time filter

Source Type


Hou H.,Zhejiang University | Hou H.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province | Wang C.,Beijing 307 Hospital | Jia S.,Peking University | And 3 more authors.
Neuroscience Bulletin | Year: 2014

Dopamine (DA) is considered crucial for the rewarding effects of drugs of abuse, but its role in addiction remains unclear. Positron emission tomography (PET) is the first technology used for in vivo measurement of components of the dopaminergic system in the human brain. In this article, we review the major findings from PET imaging studies on the involvement of DA in drug addiction, including presynaptic DA synthesis, vesicular monoamine transporter 2, the DA transporter, and postsynaptic DA receptors. These results have corroborated the role of DA in addiction and increased the understanding of its underlying mechanisms. © 2014, Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg. Source


Chao F.,Zhejiang University | Chao F.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province | Zhang H.,Zhejiang University | Zhang H.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province
Journal of Biomedicine and Biotechnology | Year: 2012

Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT), combining anatomic information of CT and metabolic information of PET, is emerging as a potential diagnosis and staging test in patients with non-small-cell lung cancer (NSCLC). The purpose of this paper is to discuss the value of integrated PET/CT in the staging of the non-small-cell lung cancer and its health economics. Copyright © 2012 Fangfang Chao and Hong Zhang. Source


Li J.-H.,Zhejiang University | Li J.-H.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province | Lu J.,Zhejiang University | Zhang H.,Zhejiang University | Zhang H.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province
Evidence-based Complementary and Alternative Medicine | Year: 2013

Objective. To investigate neuroprotective effects of scutellarin (Scu) in a rat model of cerebral ischemia with use of 18F-fluorodeoxyglucose (18F-FDG) micro positron emission tomography (microPET). Method. Middle cerebral artery occlusion was used to establish cerebral ischemia. Rats were divided into 5 groups: sham operation, cerebral ischemia-reperfusion untreated (CIRU) group, Scu-25 group (Scu 25 mg/kg/d), Scu-50 group (Scu 50 mg/kg/d), and nimodipine (10 mg/Kg/d). The treatment groups were given for 2 weeks. The therapeutic effects in terms of cerebral infarct volume, neurological deficit scores, and cerebral glucose metabolism were evaluated. Levels of vascular density factor (vWF), glial marker (GFAP), and mature neuronal marker (NeuN) were assessed by immunohistochemistry. Results. The neurological deficit scores were significantly decreased in the Scu-50 group compared to the CIRU group (P < 0.001). 18F-FDG accumulation in the ipsilateral cerebral infarction increased steadily over time in Scu-50 group compared with CIRU group (P < 0.01) and Scu-25 group (P < 0.01). Immunohistochemical analysis demonstrated Scu-50 enhanced neuronal maturation. Conclusion. 18F-FDG microPET imaging demonstrated metabolic recovery after Scu-50 treatment in the rat model of cerebral ischemia. The neuroprotective effects of Scu on cerebral ischemic injury might be associated with increased regional glucose activity and neuronal maturation. © 2013 Jin-hui Li et al. Source


Hou H.,Zhejiang University | Hou H.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province | Hou H.,Peking University | Jia S.,Peking University | And 6 more authors.
Journal of Biomedicine and Biotechnology | Year: 2012

In recent years, internet addiction disorder (IAD) has become more prevalent worldwide and the recognition of its devastating impact on the users and society has rapidly increased. However, the neurobiological mechanism of IAD has not bee fully expressed. The present study was designed to determine if the striatal dopamine transporter (DAT) levels measured by T 99m c -TRODAT-1 single photon emission computed tomography (SPECT) brain scans were altered in individuals with IAD. SPECT brain scans were acquired on 5 male IAD subjects and 9 healthy age-matched controls. The volume (V) and weight (W) of bilateral corpus striatum as well as the T 99m c -TRODAT-1 uptake ratio of corpus striatum/the whole brain (Ra) were calculated using mathematical models. It was displayed that DAT expression level of striatum was significantly decreased and the V, W, and Ra were greatly reduced in the individuals with IAD compared to controls. Taken together, these results suggest that IAD may cause serious damages to the brain and the neuroimaging findings further illustrate IAD is associated with dysfunctions in the dopaminergic brain systems. Our findings also support the claim that IAD may share similar neurobiological abnormalities with other addictive disorders. Copyright © 2012 Haifeng Hou et al. Source


Wang J.,Zhejiang University | Wang J.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province | Tian M.,University of Texas M. D. Anderson Cancer Center | Zhang H.,Zhejiang University | Zhang H.,Key Laboratory of Medical Molecular Imaging of Zhejiang Province
European Journal of Nuclear Medicine and Molecular Imaging | Year: 2011

Human neurological diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, spinal cord injury and multiple sclerosis are caused by loss of different types of neurons and glial cells in the brain and spinal cord. At present, there are no effective therapies against these disorders. Discovery of the therapeutic potential of stem cells offers new strategies for the treatment of neurological diseases. Direct assessment of stem cells' survival, interaction with the host and impact on neuronal functions after transplantation requires advanced in vivo imaging techniques. Positron emission tomography (PET) is a potential molecular imaging modality to evaluate the viability and function of transplanted tissue or stem cells in the nervous system. This review focuses on PET molecular imaging in stem cell therapy for neurological diseases. © Springer-Verlag 2011. Source

Discover hidden collaborations